FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)
$11.24 -0.01 (-0.0889%)
Analysed FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) News Sources
Assessing Fresenius SE KGaA (XTRA:FRE) Valuation After Recent Earnings And Shareholder Returns
01-03-2026
yahoo.com
Here's Why Fresenius (FMS) is a Strong Value Stock
05-03-2026
yahoo.com
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
13-03-2026
yahoo.com
CMS Grants Fresenius Kabi COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg)
09-04-2026
yahoo.com
Quest Diagnostics Q1 Earnings Call Highlights
21-04-2026
marketbeat.com
How The Fresenius SE KGaA (XTRA:FRE) Investment Story Is Evolving With Mixed Analyst Targets
23-04-2026
yahoo.com
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson
21-05-2026
yahoo.com
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
29-05-2026
yahoo.com
Fresenius (FMS) Q1 2026 Earnings Transcript
01-06-2026
fool.com
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
15-06-2026
yahoo.com
What is the current price of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The current price of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is $11.24.
FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) since the previous trading day is $-0.01.
FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) since the previous trading day is -0.0889%.
What is the most recent average sentiment score for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The most recent average sentiment score for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is 76 out of 100.
What is the most recent average sentiment for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The most recent sentiment for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is .
SEC-8K** Filing Available For FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.